← Back to Methodology
RQS Scoring Log

DSIP

Nootropics & Neuroprotection· Observational· Scored May 2026· View compound profile →
37 /100
Weak Evidence
7 dimensions · 100 points total · Methodology by PeptideClear
Dimension Breakdown
DimensionScoring NotesScore
Study Design
Human observational and some controlled studies for sleep disorders, pain, and stress in 1980s-1990s European (mainly Swiss/German) research. Older literature base, no modern RCT.
15 / 25
Sample Size
Small studies typical of 1980s neuropeptide research — usually 10-30 subjects. No large modern trials.
4 / 20
Replication
Some replication across European groups in the 1980s but research effectively stalled since ~1995. No modern independent replication.
5 / 20
Journal Impact Factor
Published in Peptides journal (IF ~3), Experientia, Pharmacology Biochemistry and Behavior (IF ~3). Older mid-tier journals.
4 / 15
Funding Independence
Academic European (Swiss SNSF, German DFG) funded. Independent from commercial interests.
4 / 10
Population Diversity
Predominantly small European cohorts. Limited diversity.
3 / 5
Researcher h-Index
Primary DSIP researchers (Monnier, Graf, Schoenenberger) are retired/deceased. h-Index not current or findable in modern databases.
2 / 5